EUCTR2005-002611-25-AT进行中（未招募）不适用
An open-label extension trial to investigate the safety and tolerability of long-term treatment with transdermal rotigotine in subjects with idiopathic restless legs syndrome
Schwarz Biosciences GmbH0 个研究点目标入组 420 人开始时间: 2005年11月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 420
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Subject is informed and given ample time and opportunity to think about her/his participation and has given her/his written informed consent.
- •2. Subject completed the Maintenance Period and Taper Period of SP790 or SP794.
- •3. Subject understands the investigational nature of the trial and is willing and able to comply with the trial requirements.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Subject has an ongoing serious adverse event (SAE) from SP790 or SP794 that is assessed to be related to the trial medication by the investigator and/or the sponsor.
- •2. Subject is pregnant, nursing, or is a woman of child-bearing potential who is not surgically sterile, 2 years postmenopausal, or does not consistently use 2 combined effective methods of contraception, including at least 1 barrier method, unless sexually abstinent.
- •3. Subject has any medical or psychiatric condition that, in the opinion of the investigator, can jeopardize or would compromise the subject’s ability to participate in this trial.
研究者
相似试验
进行中（未招募）
1 期
An open-label extension trial to investigate the safety and tolerability of long-term treatment with transdermal rotigotine in subjects with idiopathic restless legs syndromeRestless Leg's SyndromeMedDRA version: 7.0Level: LLTClassification code 10058920EUCTR2005-002611-25-ESSchwarz Biosciences GmbH510
进行中（未招募）
不适用
An open-label extension trial to investigate the safety and tolerability of long-term treatment with transdermal rotigotine in subjects with idiopathic restless legs syndromeEUCTR2005-002611-25-DESchwarz Biosciences GmbH420
进行中（未招募）
不适用
An open-label extension trial to investigate the safety and tolerability of long-term treatment with transdermal rotigotine in subjects with idiopathic restless legs syndromeRestless Leg's SyndromeMedDRA version: 7.0Level: LLTClassification code 10058920EUCTR2005-002611-25-FISchwarz Biosciences GmbH420
进行中（未招募）
不适用
An open-label extension trial to investigate the safety and tolerability of long-term treatment with transdermal rotigotine in subjects with idiopathic restless legs syndromeRestless Leg's SyndromeMedDRA version: 9.1Level: LLTClassification code 10058920Term: Restless legs syndromeEUCTR2005-002611-25-SESchwarz Biosciences GmbH510
进行中（未招募）
1 期
An open label extension trial to investigate the safety and tolerability of long-term treatment with transdermal rotigotine in subjects with idiopathic restless legs syndromeEUCTR2005-002611-25-GBSCHWARZ BIOSCIENCES GmBH420